DK586685A - Antitumor-aktivt stof, fremgangsmaade til dets fremstilling, laegemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme - Google Patents

Antitumor-aktivt stof, fremgangsmaade til dets fremstilling, laegemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme

Info

Publication number
DK586685A
DK586685A DK586685A DK586685A DK586685A DK 586685 A DK586685 A DK 586685A DK 586685 A DK586685 A DK 586685A DK 586685 A DK586685 A DK 586685A DK 586685 A DK586685 A DK 586685A
Authority
DK
Denmark
Prior art keywords
substance
genet
antitumor
procedure
manufacturing
Prior art date
Application number
DK586685A
Other languages
English (en)
Other versions
DK172052B1 (da
DK586685D0 (da
Inventor
Satoru Nakai
Mayumi Kaneta
Yoshikazu Kikumoto
Yeong-Man Hong
Kazuyoshi Kawai
Setsuko Takegata
Kiyoshi Ishii
Yasuo Yanagihara
Yoshikatsu Hirai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP60283238A external-priority patent/JPS62142121A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DK586685D0 publication Critical patent/DK586685D0/da
Publication of DK586685A publication Critical patent/DK586685A/da
Application granted granted Critical
Publication of DK172052B1 publication Critical patent/DK172052B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK586685A 1984-12-21 1985-12-17 Antitumor-aktivt stof, fremgangsmåde til dets fremstilling, lægemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme transformet med en sådan vektor DK172052B1 (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP27120784 1984-12-21
JP27120784 1984-12-21
JP13828085 1985-06-24
JP13828085 1985-06-24
JP13828185 1985-06-24
JP13828185 1985-06-24
JP22088285 1985-10-03
JP22088285 1985-10-03
JP28323885 1985-12-16
JP60283238A JPS62142121A (ja) 1985-12-16 1985-12-16 抗腫瘍活性物質

Publications (3)

Publication Number Publication Date
DK586685D0 DK586685D0 (da) 1985-12-17
DK586685A true DK586685A (da) 1986-06-22
DK172052B1 DK172052B1 (da) 1997-09-29

Family

ID=27527509

Family Applications (1)

Application Number Title Priority Date Filing Date
DK586685A DK172052B1 (da) 1984-12-21 1985-12-17 Antitumor-aktivt stof, fremgangsmåde til dets fremstilling, lægemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme transformet med en sådan vektor

Country Status (5)

Country Link
US (1) US4898818A (da)
EP (1) EP0187991B1 (da)
KR (1) KR930012106B1 (da)
DE (2) DE187991T1 (da)
DK (1) DK172052B1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0569687B1 (en) * 1984-05-18 2002-08-21 New England Medical Center Hospitals, Inc. Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
US5998578A (en) * 1984-05-18 1999-12-07 New England Medical Center Hospitals, Inc. Biologically active fragments of IL-1β
CA1341433C (en) * 1984-06-19 2003-06-24 Douglas P. Cerretti Purification of interleukin 1
JP2583770B2 (ja) 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
DK590387A (da) * 1986-11-13 1988-05-14 Otsuka Pharma Co Ltd Antistoffer mod interleukin-1
US5047505A (en) * 1987-01-27 1991-09-10 Du Pont Merck Pharmaceutical Company High level expression in E. coli of soluble mature HIL-1beta and derivatives with altered biological activity
EP0644203A1 (en) * 1988-07-29 1995-03-22 Otsuka Pharmaceutical Co., Ltd. IL-1alpha derivatives and medicament for treating thrombocytopenia
FR2636231A1 (fr) * 1988-09-09 1990-03-16 Sanofi Sa Cellules eucaryotes recombinees productrices d'interleukine-1 (beta) mature n-glycosylee, procede et vecteurs necessaires pour leur obtention et procede d'obtention d'interleukine-1 (beta) mature n-glycosylee
EP0364778B1 (en) * 1988-10-01 1996-03-13 Otsuka Pharmaceutical Co., Ltd. Antibody against interleukin-1beta
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
DE3907244A1 (de) * 1989-03-07 1990-09-13 Knoll Ag Erzeugnisse, enthaltend ein lithiumsalz und einen tumor-nekrose-faktor
DE3922089A1 (de) * 1989-05-09 1990-12-13 Basf Ag Neue proteine und ihre herstellung
US6262239B1 (en) 1989-05-18 2001-07-17 Yeda Research And Development Co., Ltd. TNF receptor-specific antibodies
US6232446B1 (en) 1989-05-18 2001-05-15 Yeda Research And Development Co. Ltd. TNF ligands
US5849282A (en) * 1990-05-09 1998-12-15 Otsuka Pharmaceutical Co., Ltd. Method of treating colon, renal, and lung carcinomas with γ-interferon and Ser71 !-interleukin-1β
US5723117A (en) * 1990-08-10 1998-03-03 Otsuka Pharmaceutical Co., Ltd. Use of interleukin-1 (IL-1) to inhibit development of hepatitis
US6446032B1 (en) * 1990-09-21 2002-09-03 Massachusetts Institute Of Technology Designing compounds specifically inhibiting ribonucleic acid by binding to the minor groove
GB9112553D0 (en) * 1991-06-11 1991-07-31 Wellcome Found Fusion proteins
US7276335B1 (en) * 1993-09-29 2007-10-02 Massachusetts Institute Of Technology Designing compounds specifically inhibiting ribonucleic acid function
US6120770A (en) * 1997-09-12 2000-09-19 University Of Notre Dame Du Lac Plasmodium proteins useful for preparing vaccine compositions
GB9916630D0 (en) * 1999-07-16 1999-09-15 Univ Manchester Molecules derived from interleukins
GB0525866D0 (en) * 2005-12-20 2006-02-01 Cambridge Microbial Technologi Chemical induction of quiescence in cells
EP2598526B1 (en) 2010-07-29 2018-09-05 Eleven Biotherapeutics, Inc. Chimeric il-1 receptor type i agonists and antagonists
SG10201707477SA (en) 2013-03-13 2017-10-30 Eleven Biotherapeutics Inc Chimeric cytokine formulations for ocular delivery

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56026B1 (en) * 1982-10-19 1991-03-27 Cetus Corp Cysteine-depleted muteins of biologically active proteins
FR2550802B1 (fr) * 1983-08-17 1986-04-11 Inst Nat Sante Rech Med Procede de production d'interleukine 1 humaine et medicaments correspondants
JPS60149386A (ja) * 1984-01-17 1985-08-06 Dainippon Pharmaceut Co Ltd インタ−ロイキン１をコ−ドする伝令リボ核酸及びその調製法
CA1341401C (en) * 1984-03-23 2002-11-26 Adriano Fontana Immunosuppressant factor derived from human glioblastoma cells
EP0155433A1 (en) * 1984-03-23 1985-09-25 Adriano Fontana Immunosuppressant factor
EP0569687B1 (en) * 1984-05-18 2002-08-21 New England Medical Center Hospitals, Inc. Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
US4762914A (en) * 1984-05-18 1988-08-09 Auron Philip E Truncated protein of interleukin-1
DE3587669T2 (de) * 1984-05-18 1994-03-31 Massachusetts Inst Technology Menschliche IL-1-cDNS-Sequenzen die für biologisch aktive menschliche IL-1-Proteine kodieren.
CA1341433C (en) * 1984-06-19 2003-06-24 Douglas P. Cerretti Purification of interleukin 1
EP0188920B1 (en) * 1984-12-25 1993-09-29 Dainippon Pharmaceutical Co., Ltd. Interleukin 1 and its derivative
AU577856B2 (en) * 1985-01-17 1988-10-06 Immunex Corporation Cloning and characterization of the human interleukin 1 gene
DE3683186D1 (de) * 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.

Also Published As

Publication number Publication date
EP0187991A2 (en) 1986-07-23
KR930012106B1 (ko) 1993-12-24
EP0187991A3 (en) 1988-03-16
DK172052B1 (da) 1997-09-29
DK586685D0 (da) 1985-12-17
KR860005022A (ko) 1986-07-16
DE187991T1 (de) 1987-04-30
US4898818A (en) 1990-02-06
EP0187991B1 (en) 1992-05-13
DE3586050D1 (da) 1992-06-17

Similar Documents

Publication Publication Date Title
DK586685A (da) Antitumor-aktivt stof, fremgangsmaade til dets fremstilling, laegemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme
DK458480A (da) Dna, recombinant plasmid og mikroorganisme indeholdende dette samt fremgangsmaader til fremstilling deraf
DK162099C (da) Antibiotika, fremgangsmaade til fremstilling deraf samt mikroorganismer til anvendelse ved fremgangsmaaden
ZA884894B (en) Haloarylnitrile degrading gene,its use,and cells containing the gene
EP0190254A4 (en) GENE CLONE AND PROCESS FOR THE PREPARATION AND USE THEREOF.
EP0177568A4 (en) RECOMBINANT DNA MOLECULES.
IL81168A0 (en) Haloarylnitrile degrading gene,its use,and cells containing the same
ES8706726A1 (es) Un metodo de purificar activador de plasminogeno de tejido uterino
DE3881063D1 (de) Tdma-system und methode geschickt zur individuellen kontrolle der elektrischen staerke von data-bursts.
DK568587A (da) Dna fragmenter indeholdende alkalisk cellulasegen, rekombinante plasmider indeholdende disse dna fregmenter og rekombinante mikroorganismer
NO863503D0 (no) Fremgangsmaate til fremstilling av 6-metyl-4,3-dihydro-1,2,3-oksatiazin-4-on-2,2-dioksyd, samt til dets fremstilling.
IT1176915B (it) Impianto di controllo e procedimento per il riempimento ponderale di bottiglie, flaconi e simili
GB2184736B (en) Control of polymerization temperature.
EP0077664A3 (en) Recombinant dna and coliform bacillus having genetic material for the production of staphylokinase, and the production of staphylokinase
DK509985D0 (da) Antibiotisk polypeptid, fremgangsmaade til dets fremstilling samt dets anvendelse
NO168225C (no) Produkt med hylster, samt fremgangsmaate for dets fremstilling.
EP0303859A3 (en) Cloning of dna encoding antibacterial polypeptide precursor and expression of the precursor
DK538386A (da) Streptomycin-sensitivt gen, plasmidvektor indeholdende dette samt mikroorganisme indeholdende vektoren
GB2168705B (en) Novel bacteriolytic enzyme and process for preparing the same
EP0303858A3 (en) Cloning of dna encoding antibacterial polypeptide precursor and expression of the precursor
DK631386D0 (da) 1-carbacephalosporin-antibiotika, fremgangsmaade til fremstilling deraf samt mellemprodukter til brug ved fremgangsmaaden
AU6655190A (en) Novel polypeptides having growth factor activity and nucleic acid sequences encoding the polypeptides
DK605985A (da) Plasmid, fremgangsmaade til fremstilling og mikroorganisme indeholdende samme samt fremgangsmaade til dyrkning af mikroorganismen
Strauch Tensor products of Banach spaces with unconditional bases
PL252672A2 (en) Tunnel furnace with stabilized pressure distribution within its tunnel

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed